Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents		$ 5,238	$ 10,787
Restricted cash		25	27
Other current assets		568	116
Total current assets		5,831	10,930
Fixed assets, net		259	90
Total assets		6,090	11,020
Current liabilities:
Trade payables		630	78
Accrued liabilities		755	450
Other accrued liabilities		3,375
Total current liabilities		4,760	528
Long-term liabilities:
Derivative warrant liability		8	28
Total Long-term liabilities		8	28
Total liabilities		4,768	556
Commitments and contingencies
Temporary equity:
Common stock of $0.01 par value; issued and outstanding: 0 and 721,107 shares as of December 31, 2018 and 2017			500
Shareholders' equity:
Preferred stock of $0.01 par value; Authorized: 1,000,000 shares as of December 31, 2018 and 2017; issued and outstanding: 0 and 4,001 shares as of December 31, 2018 and 2017, respectively				[1]
Common stock of $0.01 par value; Authorized: 220,000,000 as of December 31, 2018 and 2017; issued and outstanding (**): 3,012,343 and 2,013,193 shares as of December 31, 2018, and December 31, 2017, respectively	[2]	31	27
Additional paid-in capital		32,530	30,561
Treasury shares		(3,375)
Accumulated deficit		(27,864)	(20,624)
Total shareholders' equity		1,322	9,964
Total liabilities and shareholders' equity		$ 6,090	$ 11,020

[1] Less than 1

[2] December 31 2017 share data represents the number of shares adjusted to retroactively reflect the 1:15 reverse stock split effected on September 4, 2018. Refer to Note 1 for further information.